
Friday, April 04, 2025 2:57:00 PM
They create artificial downward pressure to induce panic selling, depress market sentiment, and gain favorable cover prices.The tactic is to βshake the treeβ before the fruit drops.
Just before positive news or a potential breakout, these players exploit low liquidity and investor anxiety to accumulate or cover positions silently.
Volume: | 12,179,951 |
Day Range: | 0.251 - 0.3608 |
Bid: | 0.35 |
Ask: | 0.352 |
Last Trade Time: | 4:00:06 PM EDT |
Total Trades: | 2,935 |
Recent NWBO News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] β’ Edgar (US Regulatory) β’ 03/31/2025 09:23:24 PM
- Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments β’ AllPennyStocks.com β’ 01/13/2025 01:56:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] β’ Edgar (US Regulatory) β’ 12/26/2024 10:07:47 PM
- Form 8-K - Current report β’ Edgar (US Regulatory) β’ 12/26/2024 09:29:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] β’ Edgar (US Regulatory) β’ 11/12/2024 09:10:53 PM
- Form 8-K - Current report β’ Edgar (US Regulatory) β’ 11/01/2024 09:24:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities β’ Edgar (US Regulatory) β’ 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities β’ Edgar (US Regulatory) β’ 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] β’ Edgar (US Regulatory) β’ 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities β’ Edgar (US Regulatory) β’ 08/08/2024 08:30:09 PM
- Form 8-K - Current report β’ Edgar (US Regulatory) β’ 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities β’ Edgar (US Regulatory) β’ 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher β’ AllPennyStocks.com β’ 06/17/2024 04:40:00 PM
- Form 8-K - Current report β’ Edgar (US Regulatory) β’ 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements β’ Edgar (US Regulatory) β’ 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements β’ Edgar (US Regulatory) β’ 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] β’ Edgar (US Regulatory) β’ 05/10/2024 09:04:57 PM
VAYK Corrects Major Clerical Error to Report $668K Operating Revenue for 2024 β’ VAYK β’ Apr 17, 2025 9:00 AM
UAV Corp Names David Dugas as President and Chief Operating Officer β’ UMAV β’ Apr 17, 2025 8:30 AM
Yuengling's Ice Cream Corporation (OTC: YCRM), Doing Business as ReachOut, Files 2024 10-K With Profitability, Growth, and Corporate Transformation in Focus β’ YCRM β’ Apr 16, 2025 11:07 AM
Avant Technologies and JV Partner, Ainnova, Accelerate Expansion Across Latin America Following Key Role at Healthcare Innovation Summit β’ AVAI β’ Apr 16, 2025 8:00 AM
HealthLynked Welcomes Anthony Scuilla as Sales Consultant to Drive Strategic Partnerships with Insurance Providers β’ HLYK β’ Apr 14, 2025 8:00 AM
Glidelogic Corp. Partners with Sunwah Global Youth Innovation Center β’ GDLG β’ Apr 10, 2025 4:00 PM